Arrowhead Pharmaceuticals, Inc.
$ARWR
Public valuation for Arrowhead Pharmaceuticals, Inc. (ARWR). Fair value, signal, and key metrics — no sign-in required.
Current Price
$59.90
80% Overvalued
Fair Value Estimate
$12
📉
Distressed
Negative earnings with declining revenue
Analyst Consensus
Target: $107.71
80% higher than current
Key Metrics
Market Cap
$8.5B
Forward P/E
111.1x
Operating Margin
-226.0%
Revenue Growth
-27.9%
Get free watchlist alerts
Join the waitlist for valuation updates on $ARWR and the rest of your watchlist.
Join the waitlistJoin the waitlist
Stay on this page to join — no sign-in required.